Lv11
70 积分 2025-10-24 加入
Locoregionally delivered PD-1 blockade augments B7-H3 targeting CAR T cell efficacy in models of glioblastoma
52分钟前
待确认
China now leads the world in trials for next-gen CAR-T therapies
27天前
已关闭
FOXP1 Knockdown Reprograms Th9 CAR‐T Cells to Overcome Antigen Escape
28天前
已完结
Cancer-driver-agnostic targeting of amplified surface proteins identifies MPZL1 for selective CAR-T cell therapy
1个月前
已完结
Enhancement of antibody-dependent cytotoxicity with a chimeric anti-GD2 antibody
1个月前
已完结
Calibration of CAR signaling promotes asymmetric cell division to direct CAR-T cell fate and antitumor potency
2个月前
已完结
FECH, a novel metabolic target influencing CAR T-cell phenotype and function
2个月前
已完结
H2AFY2 suppresses exhaustion and enhances antitumor activity of CAR-T cells through transcriptional and epigenetic modifications
2个月前
已完结
High-avidity cathepsin-G–specific CAR T cells for the treatment of acute myeloid leukemia
2个月前
已完结
NK-92MI Cells Engineered with Anti-claudin-6 Chimeric Antigen Receptors in Immunotherapy for Ovarian Cancer
2个月前
已完结
皖公网安备34019202002308
